FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug-Eluting Peripheral Transluminal Angioplasty Catheter

PMA: P140010 · Supplement: S098 · Decision Mar 6, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P140010 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Trade Name
IN.PACT™ 018 Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter
PMA Number
P140010
Supplement Number
S098
Device Class
FDA Class 3
Product Code
ONU
Generic Name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 6, 2026
Date Received
July 24, 2025
Supplement Type
Normal 180 Day Track
Supplement Reason
Change Design/Components/Specifications/Material
Expedited Review
N

Advisory Committee Statement

addition of 200 mm and 250 mm balloon lengths to the commercially available IN.PACT 018 Paclitaxel-coated PTA Balloon Catheter size matrix

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
ONU Drug-Eluting Peripheral Transluminal Angioplasty Catheter